Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)

Completed

• Conditions: Overactive Bladder; Incontinence, Daytime Urinary; Incontinence, Nighttime Urinary

• Registration Number: NCT06569342
• Lead Sponsor: University of Aarhus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-16
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - OAB<br><br> - Intradetrusor BoNT-A<br><br>Exclusion Criteria:<br><br> - Neurogenic OAB

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incontinence episodes

Secondary Outcome Measures

Name	Time	Method
Response;Side effects